NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $172,000 | -61.9% | 14,161 | +7.0% | 0.00% | -100.0% |
Q4 2021 | $451,000 | -30.7% | 13,238 | -2.0% | 0.00% | -50.0% |
Q3 2021 | $651,000 | +80.8% | 13,510 | +69.1% | 0.00% | +100.0% |
Q2 2021 | $360,000 | -2.4% | 7,987 | +4.3% | 0.00% | 0.0% |
Q1 2021 | $369,000 | -10.7% | 7,658 | -0.2% | 0.00% | 0.0% |
Q4 2020 | $413,000 | -64.2% | 7,677 | -75.5% | 0.00% | -75.0% |
Q3 2020 | $1,153,000 | +17.3% | 31,278 | -1.5% | 0.00% | 0.0% |
Q2 2020 | $983,000 | +15.2% | 31,751 | +2.7% | 0.00% | 0.0% |
Q1 2020 | $853,000 | -1.4% | 30,915 | +4.4% | 0.00% | +33.3% |
Q4 2019 | $865,000 | +44.4% | 29,603 | -5.6% | 0.00% | 0.0% |
Q3 2019 | $599,000 | +6.6% | 31,353 | +22.2% | 0.00% | +50.0% |
Q2 2019 | $562,000 | +11.3% | 25,647 | +3.8% | 0.00% | 0.0% |
Q1 2019 | $505,000 | +64.0% | 24,702 | +0.9% | 0.00% | 0.0% |
Q4 2018 | $308,000 | -17.4% | 24,480 | +0.7% | 0.00% | 0.0% |
Q3 2018 | $373,000 | +65.8% | 24,300 | +41.3% | 0.00% | +100.0% |
Q2 2018 | $225,000 | +60.7% | 17,200 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $140,000 | -7.9% | 17,200 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $152,000 | – | 17,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |